Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window

Inside Pharmaceuticals & Biotech

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


wsbtv.com > news > local > atlanta > measles-outbreak-rise-metro-atlanta-what-parents-need-know-outbreak-grows > AGG63K3UGZGGHGVLHTQHCFZKWQ

Measles outbreak rise in metro Atlanta: What parents need to know as outbreak grows

44+ min ago   (478+ words) ATLANTA — A measles outbreak linked to a metro Atlanta daycare is growing, with two new cases bringing the total number of cases connected to the daycare to 10. The Georgia Department of Public Health has confirmed 16 measles cases statewide so far…...


westchester.news12.com > connecticut-judge-upholds-school-vaccine-requirements-dismissal-of-challenge-to-religious-exemption-ban

Connecticut judge upholds school vaccine requirements, dismissal of challenge to religious exemption ban

5+ hour, 20+ min ago   (170+ words) Sep 15, 2026, 11:53 AM A Connecticut judge has upheld the state's ban on religious exemptions for school vaccinations, dismissing a legal challenge brought by several parents. The lawsuit argued that Connecticut's policy violated the state's 1993 Religious Freedom Restoration Act. However, lawmakers amended…...


senatedems.ct.gov > looney-duff-on-court-upholding-school-vaccine-requirements-2

Looney, Duff on Court Upholding School Vaccine Requirements

6+ hour, 15+ min ago   (151+ words) Connecticut Senate Democrats (.gov) Looney, Duff on Court Upholding School Vaccine Requirements “This ruling is a win for every Connecticut parent who sends a child to school expecting that classroom to be safe from measles. With 98.2 percent of Connecticut kindergartners…...


contractpharma.com > breaking-news > axiom-genefab-partner-to-advance-therapeutic-pipeline

Axiom, GeneFab Partner to Advance Therapeutic Pipeline

4+ hour, 58+ min ago   (301+ words) Editor’s Take: Partnerships like this often serve to build the manufacturing infrastructure necessary to support the continued advance of therapeutic candidates. Axiom Biosciences announced a strategic partnership with GeneFab aimed at continuing to advance Axiom’s therapeutic pipeline. In this collaboration,…...


markets.businessinsider.com > news > stocks > biovie-announces-topline-results-from-phase-2-address-lc-trial-evaluating-bezisterim-for-the-treatment-of-neurological-symptoms-associated-with-long-covid-1036546208

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

9+ hour, 51+ min ago   (199+ words) Bezisterim showed a consistent advantage over placebo on 21 out of 22 individual endpoints in the overall study population An estimated 17–20 million U.S. adults live with Long COVID and currently have no FDA‑approved treatment options Conference call scheduled for 8:30 a.m....


plexusdx.com > blogs > learn > emerge-weight-loss-pricing-dose-tiered-costs-long-term-treatment-plexusdx

Emerge Weight Loss Pricing: Dose Costs and Long-Term Treatment Plans – PlexusDx

1+ hour, 53+ min ago   (1235+ words) Shop all 5 Weight Loss programs → Compare GLP-1 providers → Start Weight Loss intake → Shop all 5 Longevity programs → Start Longevity intake → GLP-1 & Peptide Pathways Food Sensitivity & Allergies Diet & Weight Loss Cognition and Brain Health Genetic Test Stress and Mental Health Genetic Test…...


prnewswire.com > news-releases > hdt-bio-receives-arpa-h-give-award-to-lead-development-of-automated-point-of-care-manufacturing-for-personalized-rna-medicines-302878198.html

HDT Bio Receives ARPA-H GIVE Award to Lead Development of Automated, Point-of-Care Manufacturing for Personalized RNA Medicines

5+ hour, 44+ min ago   (225+ words) Sep 15, 2026, 12:00 ET Award of up to $39.5 million funds a closed, end-to-end RNA manufacturing and quality-control platform; program includes a personalized cancer immunotherapy demonstration with Houston Methodist Research Institute and marks HDT Bio's expansion into personalized cancer medicine A Closed, End-to-End…...


mmm-online.com-online.com

Live from Fierce Pharma Week 2026: Highlights from Philadelphia

57+ min ago   (791+ words) The MM+M editorial team is in Philadelphia this week, providing running commentary from the conference. Given ongoing mistrust and skepticism around the pharma industry, discussing how to rebuild trust is always simmering in the background of conferences, marketers told…...


prnewswire.com > news-releases > blood-cancer-united-announces-7-5-million-gift-from-royalty-pharma-to-expand-therapy-acceleration-program-302879539.html

Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program

1+ hour, 14+ min ago   (219+ words) Sep 15, 2026, 16:30 ET Donation marks a new phase for Blood Cancer United's venture philanthropy program, with returns reinvested to support future therapies Founded in 2007, TAP was created to help move promising blood cancer therapies into clinical development faster. As it approaches…...


medpagetoday.com > psychiatry > generalpsychiatry > 123014

Psychedelic Drug Trials, Patient Safety Take Spotlight at FDA Hearing

48+ min ago   (573+ words) — Agency heard public testimony about psychedelic treatments for severe mental illness The FDA gathered public feedback Monday during a 4-hour hearing about potential therapeutic use of psychedelic drugs. Most of the hearing's 80 speakers offered strong support for psychedelic medicine, highlighting its…...